Status:
UNKNOWN
Follow-up of Critical COVID-19 Patients
Lead Sponsor:
Uppsala University
Collaborating Sponsors:
Uppsala University Hospital
Conditions:
COVID19
ARDS
Eligibility:
All Genders
18+ years
Brief Summary
The study will follow COVID-19 patients who required intensive care after 3-6 months and one year after discharge from the ICU with functional level as well as organ function to assess recovery after ...
Detailed Description
The study will follow COVID-19 patients who required intensive care at Uppsala University Hospital and were included in the Uppsala COVID-19 biobank. The patients will be contacted after three to six ...
Eligibility Criteria
Inclusion
- PCR-verified Covid-19
- Treated in ICU
Exclusion
- Pregnant of breastfeeding
Key Trial Info
Start Date :
June 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04474249
Start Date
June 25 2020
End Date
December 1 2022
Last Update
October 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uppsala University Hospital
Uppsala, Sweden, 75185